Invicta Diagnostic came to market through an SME IPO that opened on 1 December 2025 and closed on 3 December 2025, and the shares listed on 8 December 2025 on NSE SME. The price band was ₹80 to ₹85 per share and one lot was 1600 shares, so the minimum application was ₹1,36,000. The issue size was ₹28.12 crore. The whole issue was fresh shares, so the money raised went to the company.
Bigshare Services Pvt Ltd was the registrar to the issue, and Socradamus Capital Pvt Ltd was the lead manager.
As of 3 December 2025.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra. Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:
A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa. It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations. Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes: Routine Tests:
Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels. Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025.
The company has 105 permanent employees as of May 31, 2025.
As described in the offer document.
| Metric | 30-Sep-25 | 31-Mar-25 | 31-Mar-24 |
|---|
Dr. Ketan Jayantilal Jain, Dr. Sanket Vinod Jain, Rohit Prakash Srivastava, Badal Kailash Naredi, Jayesh Prakash Jain.
Work out the listing gain for this SME IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Invicta Diagnostic IPO was a ₹28.12 crore book-built issue, made up entirely of a fresh issue. It was priced at ₹80–₹85 per share with a lot size of 1,600 shares; the minimum retail application was 3,200 shares (₹2,72,000). The IPO was open from December 1 to December 3, 2025 and was subscribed 4.34x. Shares listed on NSE SME on December 8, 2025 at ₹100, a 17.6% premium to the issue price of ₹85. Bigshare Services Pvt Ltd is the registrar.
Socradamus Capital Pvt Ltd is the book running lead manager.
The price band of Invicta Diagnostic IPO is ₹80 to ₹85 per share.
The lot size of Invicta Diagnostic IPO is 1600 shares.
The minimum investment for Invicta Diagnostic IPO is approximately ₹2,72,000 based on the upper price band.
The allotment date of Invicta Diagnostic IPO is Dec 4, 2025.
You can check Invicta Diagnostic IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Invicta Diagnostic IPO allotment status on Rupix for quick and easy access.
₹80 to ₹85 per share, against a face value of ₹10. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 1600 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹1,36,000. After listing, SME shares also trade in lots rather than one share at a time.
₹1,36,000, for one lot of 1600 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 1 December 2025 and closed on 3 December 2025.
The basis of allotment was published on 4 December 2025 by Bigshare Services Pvt Ltd, and allotted shares were credited to demat accounts before listing.
The shares listed on 8 December 2025 on NSE SME.
The issue size was ₹28.12 crore. The fresh issue was 33,08,800 shares (aggregating up to ₹28.12 crore).